Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Clinical Endocrinology and Metabolism is Scopus-indexed (Q1, CiteScore 11), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Endocrine Society.
Checked against the index lists dated .
ISSN 0021-972XVerify ISSN ↗1945-7197Verify ISSN ↗
Publisher: Endocrine Society
Cost to publish: About US$3,750 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 25 / 250 | 90th | Q1 |
| Clinical Biochemistry | 13 / 124 | 89th | Q1 |
| Endocrinology | 14 / 132 | 89th | Q1 |
| Biochemistry | 49 / 448 | 89th | Q1 |
| Biochemistry (medical) | 11 / 78 | 86th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1941–present, best quartile Q1, CiteScore 11.
Journal of Clinical Endocrinology and Metabolism is Q1 in Endocrinology, Diabetes and Metabolism (rank 25 of 250), Q1 in Clinical Biochemistry (rank 13 of 124) and Q1 in Endocrinology (rank 14 of 132), by CiteScore 2025. It is ranked in 5 subject areas in all.
Journal of Clinical Endocrinology and Metabolism is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.155, quartile Q1, with an H-index of 412.
The publisher lists an article processing charge of about US$3,750 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Clinical Endocrinology and Metabolism is published by Endocrine Society. Its print ISSN is 0021-972X and its online ISSN is 1945-7197.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Clinical Endocrinology and Metabolism has an h-index of 491 and a 2-year mean of 5.73 citations per paper (OpenAlex). Its Scopus CiteScore is 11, quartile Q1. On 2-year citations it ranks #25 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Journal of Clinical Endocrinology and Metabolism published 740 papers in 2025; its busiest recent year was 2020 with 996. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (30.4%), Italy (11.4%) and Japan (7.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 23 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.